Related Experiment Video
Updated: Feb 4, 2026
12:29
Population and Single-Cell Analysis of Antibiotic Persistence in Escherichia coli
Published on: March 24, 2023
2.8K
Persistent Psychosis due to Single Dose of Ecstasy
Sanya Virani1, Gulzar N Daya2, Navjot Brainch1
1Psychiatry, Maimonides Medical Center, Brooklyn, USA.
Cureus
|October 4, 2018
Summary
Recreational 3,4-Methylenedioxymethamphetamine (MDMA) use can lead to persistent psychotic symptoms, challenging the notion that its psychiatric effects are always short-term. This highlights the need for increased awareness and screening for MDMA-induced psychosis.
Area of Science:
- Neuroscience
- Psychiatry
- Toxicology
Background:
- 3,4-Methylenedioxymethamphetamine (MDMA), commonly known as Ecstasy, is a popular recreational drug.
- MDMA is primarily known for transient acute psychiatric effects, with persistent symptoms being rare.
Observation:
- A case study details a patient experiencing a psychotic state, including delusions, after recreational MDMA use.
- The patient required hospitalization due to aggressive behavior and self-harm risk.
- Persistent psychotic symptoms developed after a single recreational dose of MDMA.
Findings:
- This case suggests that MDMA can induce long-lasting neuropsychiatric symptoms.
- Research gaps exist regarding the chronic and persistent effects of MDMA.
- Neuropsychiatric symptoms following MDMA use may not always be reversible.
Implications:
- Physicians should consider MDMA use in differential diagnoses for psychosis.
- Inclusion of MDMA screening in toxicology panels is recommended.
- Further research is needed to understand the long-term neurological and psychiatric consequences of MDMA.
Related Concept Videos
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
244
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
244
01:26Psychosis: Goals of Pharmacotherapy
539
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
539
01:28Psychosis and Antipsychotic Drugs: Overview
911
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
911
01:21Dose Size and Dosing Frequency: Determination Methods
305
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
305
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
244
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
244
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.0K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.0K